EXONDYS 51

Drug Sarepta Therapeutics, Inc.
Total Payments
$10.8M
Transactions
2,054
Doctors
495
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2018 $788,009 992 400
2017 $10.0M 1,062 159

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $9.5M 368 88.6%
Consulting Fee $870,480 172 8.1%
Travel and Lodging $309,960 484 2.9%
Food and Beverage $43,512 1,026 0.4%
Grant $6,000 2 0.1%
Space rental or facility fees (teaching hospital only) $1,500 1 0.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $40.00 1 0.0%

Payments by Type

Research
$9.5M
368 transactions
General
$1.2M
1,686 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
4658-301 Sarepta Therapeutics, Inc. $7.1M 0
4658-202 Sarepta Therapeutics, Inc. $1.2M 0
4658-203 Sarepta Therapeutics, Inc. $827,735 0
4658-204 Sarepta Therapeutics, Inc. $472,476 0
Research Institute at Nationwide SRA Sarepta Therapeutics, Inc. $20,792 0

Top Doctors Receiving Payments for EXONDYS 51

Doctor Specialty Location Total Records
Unknown Salt Lake City, UT $9.6M 372
, M.D Pediatric Rehabilitation Medicine Sacramento, CA $200,168 94
Elenie Bartzokis Needham, MA $102,600 5
, MD Neuromuscular Medicine Los Angeles, CA $89,582 76
, MD Pediatrics Boston, MA $79,032 21
, MD Neurology Columbus, OH $51,139 14
, MD Neurology with Special Qualifications in Child Neurology Columbus, OH $22,974 18
, MD Neuromuscular Medicine Iowa City, IA $16,256 18
, M.D Neurology with Special Qualifications in Child Neurology Chicago, IL $15,372 14
, MD Pediatric Cardiology Gainesville, FL $15,364 20
, MD/PHD Neurology with Special Qualifications in Child Neurology Saint George, UT $15,233 15
, M.D Neurology with Special Qualifications in Child Neurology Boston, MA $15,156 16
, MD Student in an Organized Health Care Education/Training Program Brooklyn, NY $14,166 22
, MD Neurology with Special Qualifications in Child Neurology Saint Louis, MO $12,833 13
, M.D Neurology Baltimore, MD $12,318 13
, M.D Neurology Portland, OR $12,179 11
, M.D Neurology Albuquerque, NM $12,089 16
, MD Neurology Memphis, TN $11,898 21
, MD Pediatrics Fort Worth, TX $11,753 20
, M.D Neurology with Special Qualifications in Child Neurology Syracuse, NY $11,410 15
, M.D Neurology Philadelphia, PA $11,285 18
, MD Neurology with Special Qualifications in Child Neurology Palo Alto, CA $11,271 18
, MD Neurology Aurora, CO $11,001 15
, M.D Neurology with Special Qualifications in Child Neurology Norfolk, VA $10,787 15
, M.D Physical Medicine & Rehabilitation Akron, OH $10,539 13

About EXONDYS 51

EXONDYS 51 is a drug associated with $10.8M in payments to 495 healthcare providers, recorded across 2,054 transactions in the CMS Open Payments database. The primary manufacturer is Sarepta Therapeutics, Inc..

Payment data is available from 2017 to 2018. In 2018, $788,009 was paid across 992 transactions to 400 doctors.

The most common payment nature for EXONDYS 51 is "Unspecified" ($9.5M, 88.6% of total).

EXONDYS 51 is associated with 5 research studies, including "4658-301" ($7.1M).